Clinical Trial Update: A Study of Entinostat in Combination With Fulvestrant for the Treatment of Locally Advanced or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating entinostat in combination with fulvestrant for locally advanced or metastatic breast cancer, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fulvestrant (fulvestrant)
• MS-275 (entinostat) (entinostat)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Locally Advanced or Metastatic Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING